JDRF supports Janssen's DIA approach to combat type 1 diabetes

JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of Janssen Research & Development, LLC (Janssen) and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy.



from The Medical News http://ift.tt/1AiarnF